S&P 500   3,247.83 (+0.34%)
DOW   26,815.49 (+0.20%)
QQQ   265.80 (+0.62%)
AAPL   108.20 (+1.01%)
MSFT   203.63 (+1.52%)
FB   250.45 (+0.57%)
GOOGL   1,431.68 (+1.58%)
AMZN   3,048.00 (+1.60%)
NVDA   498.22 (+2.74%)
TSLA   378.66 (-0.45%)
BABA   271.11 (-0.67%)
CGC   14.46 (-0.96%)
GE   6.08 (-0.49%)
MU   49.71 (-0.28%)
AMD   76.67 (+2.60%)
T   27.89 (+0.07%)
F   6.60 (-0.60%)
ACB   5.28 (+2.13%)
GILD   62.64 (-0.71%)
NFLX   473.74 (+0.67%)
DIS   122.97 (-0.25%)
BAC   23.40 (+0.60%)
BA   149.04 (-1.42%)
S&P 500   3,247.83 (+0.34%)
DOW   26,815.49 (+0.20%)
QQQ   265.80 (+0.62%)
AAPL   108.20 (+1.01%)
MSFT   203.63 (+1.52%)
FB   250.45 (+0.57%)
GOOGL   1,431.68 (+1.58%)
AMZN   3,048.00 (+1.60%)
NVDA   498.22 (+2.74%)
TSLA   378.66 (-0.45%)
BABA   271.11 (-0.67%)
CGC   14.46 (-0.96%)
GE   6.08 (-0.49%)
MU   49.71 (-0.28%)
AMD   76.67 (+2.60%)
T   27.89 (+0.07%)
F   6.60 (-0.60%)
ACB   5.28 (+2.13%)
GILD   62.64 (-0.71%)
NFLX   473.74 (+0.67%)
DIS   122.97 (-0.25%)
BAC   23.40 (+0.60%)
BA   149.04 (-1.42%)
S&P 500   3,247.83 (+0.34%)
DOW   26,815.49 (+0.20%)
QQQ   265.80 (+0.62%)
AAPL   108.20 (+1.01%)
MSFT   203.63 (+1.52%)
FB   250.45 (+0.57%)
GOOGL   1,431.68 (+1.58%)
AMZN   3,048.00 (+1.60%)
NVDA   498.22 (+2.74%)
TSLA   378.66 (-0.45%)
BABA   271.11 (-0.67%)
CGC   14.46 (-0.96%)
GE   6.08 (-0.49%)
MU   49.71 (-0.28%)
AMD   76.67 (+2.60%)
T   27.89 (+0.07%)
F   6.60 (-0.60%)
ACB   5.28 (+2.13%)
GILD   62.64 (-0.71%)
NFLX   473.74 (+0.67%)
DIS   122.97 (-0.25%)
BAC   23.40 (+0.60%)
BA   149.04 (-1.42%)
S&P 500   3,247.83 (+0.34%)
DOW   26,815.49 (+0.20%)
QQQ   265.80 (+0.62%)
AAPL   108.20 (+1.01%)
MSFT   203.63 (+1.52%)
FB   250.45 (+0.57%)
GOOGL   1,431.68 (+1.58%)
AMZN   3,048.00 (+1.60%)
NVDA   498.22 (+2.74%)
TSLA   378.66 (-0.45%)
BABA   271.11 (-0.67%)
CGC   14.46 (-0.96%)
GE   6.08 (-0.49%)
MU   49.71 (-0.28%)
AMD   76.67 (+2.60%)
T   27.89 (+0.07%)
F   6.60 (-0.60%)
ACB   5.28 (+2.13%)
GILD   62.64 (-0.71%)
NFLX   473.74 (+0.67%)
DIS   122.97 (-0.25%)
BAC   23.40 (+0.60%)
BA   149.04 (-1.42%)
Log in
OTCMKTS:IVOB

Invo Bioscience Stock Forecast, Price & News

$4.00
0.00 (0.00 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.90
Now: $4.00
$4.00
50-Day Range
$0.22
MA: $3.93
$4.70
52-Week Range
$0.11
Now: $4.00
$0.46
Volume740 shs
Average Volume43,036 shs
Market Capitalization$630.70 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.81
INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IVOB
CUSIPN/A
CIKN/A
Phone978-878-9505

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$490,000.00
Book Value($0.02) per share

Profitability

Net Income$-3,080,000.00
Net Margins-166.95%

Miscellaneous

Employees2
Market Cap$630.70 million
Next Earnings DateN/A
OptionableNot Optionable
$4.00
0.00 (0.00 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions

How has Invo Bioscience's stock been impacted by COVID-19?

Invo Bioscience's stock was trading at $0.2288 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IVOB shares have increased by 1,648.3% and is now trading at $4.00.
View which stocks have been most impacted by COVID-19
.

How were Invo Bioscience's earnings last quarter?

Invo Bioscience Inc (OTCMKTS:IVOB) released its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.11 million for the quarter.
View Invo Bioscience's earnings history
.

Who are some of Invo Bioscience's key competitors?

What other stocks do shareholders of Invo Bioscience own?

Who are Invo Bioscience's key executives?

Invo Bioscience's management team includes the following people:
  • Ms. Kathleen T. Karloff, Chairman, CEO & Pres (Age 64)
  • Mr. Robert Joseph Bowdring Jr., Acting CFO, Acting Principal Accounting Officer, Treasurer, Sec., Consultant & Director (Age 61)
  • Mr. Michael Jos. Campbell, COO, VP of Bus. Devel. & Director (Age 61)
  • Dr. Kevin Doody, Medical Director & Director (Age 58)

What is Invo Bioscience's stock symbol?

Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."

How do I buy shares of Invo Bioscience?

Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Invo Bioscience's stock price today?

One share of IVOB stock can currently be purchased for approximately $4.00.

How big of a company is Invo Bioscience?

Invo Bioscience has a market capitalization of $630.70 million and generates $490,000.00 in revenue each year. Invo Bioscience employs 2 workers across the globe.

What is Invo Bioscience's official website?

The official website for Invo Bioscience is www.invobioscience.com.

How can I contact Invo Bioscience?

Invo Bioscience's mailing address is 5582 BROADCAST COURT, SARASOTA FL, 34240. The company can be reached via phone at 978-878-9505 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.